青娥丸通过ATM与PI3K/AKT通路抑制原发骨质疏松中成骨细胞铁死亡
本研究结合网络分析与实验验证,探讨青娥丸治疗原发骨质疏松的机制。网络分析确定青娥丸与骨质疏松的交集靶点121个,涉及156条通路,筛选出5个关键基因进行实验验证。细胞与去卵巢大鼠实验证实,青娥丸通过ATM及PI3K/AKT通路抑制铁死亡、促进成骨细胞存活,从而发挥抗骨质疏松作用。
要点
- 青娥丸抗骨质疏松机制涉及抑制成骨细胞铁死亡。
- ATM与PI3K/AKT通路是青娥丸发挥作用的关键通路。
- 网络分析联合实验验证可高效阐明中药复方机制。
核心结论
- 青娥丸通过抑制铁死亡并经由PI3K/AKT通路与ATM促进细胞存活,从而对骨质疏松发挥治疗作用。
研究设计与样本
- 研究采用网络药理学分析结合体外HFOB 1.19细胞实验与去卵巢大鼠模型实验验证。
主要发现
- 青娥丸与骨质疏松的交集靶点包含121个蛋白质,靶点-通路网络包含156条通路。
- 网络分析筛选出5个突出基因进行实验验证。
- 实验验证青娥丸通过抑制铁死亡和促进细胞存活发挥抗骨质疏松作用,涉及PI3K/AKT通路和ATM。
临床怎么用
- 本研究为青娥丸治疗原发骨质疏松提供了分子机制证据,支持其临床合理应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoporosis (OP) is an aging-related disease that is the main etiology of fragility fracture. Qing'e Pill (QEP) is a mixture of traditional Chinese medicine (TCM) consisting of Eucommia ulmoides Oliv., Psoralea corylifolia L., Juglans regia L., and Allium sativum L. QEP has an anti-osteoporosis function, but the underlying mechanism remains unclear. In this study, online databases were employed to determine the chemical compounds of QEP and potential target genes in osteoporosis. Potential pathways associated with genes were defined by Gene Ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) databases. A compound-target-disease network was constructed. Hub genes screened through Cytoscape were intersected with the FerrDB database. The potential key genes were validated in HFOB 1.19 cells, and rat models were ovariectomized through Western blot, RT-qPCR, ELISA, HE staining, immunohistochemistry, and immunofluorescence analyses. The intersection targets of QEP and osteoporosis contained 121 proteins, whereas the target-pathway network included 156 pathways. We filtered five genes that stood out in the network analysis for experimental verification. The experiments validated that QEP exerted therapeutic effects on osteoporosis by inhibiting ferroptosis and promoting cell survival via the PI3K/AKT pathway and ATM. In conclusion, combining the application of network analysis and experimental verification may provide an efficient method to validate the molecular mechanism of QEP on osteoporosis.
引用
- Hao J, Bei J, Li Z, et al. Qing`e Pill Inhibits Osteoblast Ferroptosis via ATM Serine/Threonine Kinase (ATM) and the PI3K/AKT Pathway in Primary Osteoporosis. Front Pharmacol. 2022. PMID: 35865965. doi:10.3389/fphar.2022.902102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。